AAPM Task Group Report 274: Fluence Rate Dosimetry For Photodynamic Therapy (PDT)
Research Summary
How much light reaches tissue during photodynamic therapy (PDT)? A device's output alone does not answer that question. Light is scattered and absorbed as it travels through tissue, so the light arriving from all directions at a treatment site can differ from the beam initially directed at the surface. AAPM Task Group 274 explains how to measure this light reliably using small fibre-optic detectors.
The report reviews detector technology, calibration, quality assurance and clinical implementation for surface, intracavitary and interstitial PDT. Its central message is that accurate measurements require more than an in-air calibration: the detector's response to light from different directions and the material surrounding it must also be considered. The recommendations are intended for clinical physics teams establishing or maintaining PDT dosimetry.
Who Or What Was Studied?
This is a technical task group report combining published research, detector measurements and expert recommendations, rather than a trial enrolling a single patient cohort. There is no single participant number, treatment duration or comparison group. The report focuses on scattering-tip isotropic detectors, which are designed to collect light from many directions. Fluorescence-based detectors are introduced, but their quality assurance is not developed because the authors report limited clinical use and a lack of published quality-assurance data.
What Did The Research Show?
- Irradiance describes light incident on a surface; fluence rate accounts for light from all directions at a location. Tissue scattering and absorption mean these quantities cannot simply be treated as interchangeable.
- Detector calibration must match the wavelength and measurement system used. The report recommends an integrating sphere, which creates a diffuse light field, and a power meter with calibration traceable to recognised measurement standards.
- Measurements may need a medium correction when a detector calibrated in air is placed in tissue or another material, and a backscatter correction for surface measurements. These corrections depend on the detector and treatment geometry; reference values are not universal settings.
- The task group recommends an overall clinical light-measurement accuracy target within ±15%, with the in-air detector calibration coefficient checked to within ±5% before clinical use. These are technical quality-assurance targets, not treatment-effect estimates or a recommended dose for home use.
- Initial commissioning and recurring daily, quarterly and annual checks address calibration, stability, linearity and angular response. Detector placement also matters: its blind region should not face the direct incoming light.
Limitations And Interpretation
The report does not compare clinical outcomes between treatment groups or establish the effectiveness of a consumer red light device. Some recommendations draw on task group consensus and selected detector measurements. The authors identify limited evidence for certain measurement geometries, and the correction tables explicitly require independent verification before use. Light measurement is also only one part of PDT dosimetry: photosensitiser concentration and oxygen availability influence the treatment response.
Piri Red interpretation: this paper is useful for understanding why wavelength, geometry, calibration and tissue interactions matter when discussing light exposure. PDT involves a photosensitiser-mediated treatment process and should not be conflated with routine photobiomodulation. The report does not establish a universal red light therapy session length, an optimal consumer-device dose, or benefits from Piri Red products.
Source
Zhu TC, Pogue BW, Dimofte A, Finlay JC, Lilge L, Sunar U, Simone CB II, van Veen RLP. AAPM Task Group Report 274: Fluence rate dosimetry for photodynamic therapy (PDT). Medical Physics. 2025;52(3):1354–1371. DOI: 10.1002/mp.17613.